News Pfizer Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2026-04-20 pm EDT			After hours 05:10:29 pm
27.52 ^USD	-0.15%		27.55	+0.11%

03:02pm	Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says	RE
12:38pm	Merck Announces FDA Grants Priority Review For Keytruda And Keytruda Qlex Each With Padcev For Cisplatin-Eligible Patients With Muscle-Invasive Bladder Cancer	CI

All News

03:02pm	Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says	RE
12:38pm	Merck Announces FDA Grants Priority Review For Keytruda And Keytruda Qlex Each With Padcev For Cisplatin-Eligible Patients With Muscle-Invasive Bladder Cancer	CI
12:24pm	Pfizer's Upcoming Tafamidis Bench Trial Shows Asymmetric Upside, RBC Capital Markets Says	MT
09:50am	Astellas Pharma Inc. And Pfizer Inc. Receive U.S. FDA Priority Review For PADCEV And Keytruda As Perioperative Treatment For Muscle-Invasive Bladder Cancer	CI
07:45am	Merck, Pfizer, Astellas Drug Combo Gets Speedy FDA Review in Bladder Cancer	DJ
07:43am	Merck Says FDA Grants Priority Review to Keytruda-Padcev Combo for Bladder Cancer	MT
06:46am	U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility	PR
05:24am	Pfizer, Amgen Eyeing Hong Kong Expansion	MT
Apr. 16	CICC Initiates Pfizer at Outperform With $33 Price Target	MT
Apr. 16	Harbour Biomed Appoints Adam Zong as President	CI
Apr. 15	DND Pharmatech Wins KRW1.83 Billion Anti-Obesity Drug Formulation Contract from Pfizer; Shares Rise 3%	MT
Apr. 14	Structure Therapeutics Names Matthew Lang as COO	MT
Apr. 14	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE
Apr. 13	Lineage Cell Therapeutics, Inc. Announces Formation of Scientific Advisory Board and Executive Appointment	CI
Apr. 13	UBS Raises Price Target on Pfizer to $27 From $25, Maintains Neutral Rating	MT
Apr. 13	Orum Therapeutics, Inc. Appoints Maria Koehler and Geoff Meyerson to Board of Directors	CI
Apr. 13	Earnings Season in Trump's Shadow
Apr. 13	Pfizer Renews Licensing Deal With Trellus Health for Patient Support Educational Content	MT
Apr. 13	Shares fall as oil climbs back above USD100	AN
Apr. 13	WINNERS & LOSERS: Energy stocks up; Wise gains on growth update	AN
Apr. 13	Trellus Health signs renewal of licensing deal with Pfizer	AN
Apr. 13	BMO Capital Adjusts Price Target on Pfizer to $34 From $30, Maintains Outperform Rating	MT
Apr. 13	IDEAYA and Servier's eye cancer drug meets trial goal, paving way for FDA application	RE
Apr. 13	Trellus Health Plc Signs Licensing Agreement Renewal With Pfizer Inc	CI
Apr. 13	Trellus Health, Pfizer Renew Patient Support Content License Deal	MT